We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | -3.33% | 7.25 | 7.00 | 7.50 | 7.55 | 7.25 | 7.55 | 681,334 | 13:44:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.11 | 43.52M |
From Apr 2019 to Apr 2024
TIDMKMK
RNS Number : 5268X
Kromek Group PLC
27 November 2017
27 November 2017
Kromek Group plc
("Kromek" or the "Company")
Notice of Results
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, will be announcing its interim results for the six months ended 31 October 2017 on Tuesday 19 December 2017.
The Company will be hosting a presentation to analysts at 09.00am GMT, on the day, at the offices of Luther Pendragon, 48 Gracechurch Street, London, EC3V 0EJ.
Enquiries
Kromek Group plc -------------------------------- --------------- Arnab Basu, CEO +44 (0)1740 Derek Bulmer, CFO 626 060 -------------------------------- --------------- Cenkos Securities plc -------------------------------- --------------- Bobbie Hilliam (NOMAD) +44 (0)20 7397 Julian Morse (Sales) 8900 -------------------------------- --------------- Luther Pendragon Ltd -------------------------------- --------------- Harry Chathli, Claire Norbury, +44 (0)20 7618 Alexis Gore 9100 -------------------------------- ---------------
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORFEMFWMFWSEFF
(END) Dow Jones Newswires
November 27, 2017 02:00 ET (07:00 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
